Partly Cloudy 36°
Tag:

New England Journal of Medicine

News
COVID-19: CDC Releases Results Of Study On Pfizer, Moderna Vaccine Use By Pregnant Women COVID-19: CDC Releases Results Of Study On Pfizer, Moderna Vaccine Use By Pregnant Women
Covid-19: CDC Releases Results Of Study On Pfizer, Moderna Vaccine Use By Pregnant Women Results of the largest study conducted by the Centers for Disease Control and Prevention (CDC) on the use of two-dose COVID-19 vaccines by pregnant women have been released. The new study, published this week in the New England Journal of Medicine, found that out of more than 35,000 people who were pregnant or soon to become pregnant, there is no evidence to suggest that the Pfizer or Moderna COVID vaccines pose risk during pregnancy. Little data has been released on the Johnson & Johnson one-dose vaccine, which had run into production issues before distribution was paused following rep…

SHARE

by Zak Failla
News
COVID-19: New Research Reveals Minimum Amount Of Time Moderna Vaccine Remains Effective COVID-19: New Research Reveals Minimum Amount Of Time Moderna Vaccine Remains Effective
Covid-19: New Research Reveals Minimum Amount Of Time Moderna Vaccine Remains Effective The Moderna COVID-19 vaccine could provide protection against the virus for a minimum of a half a year, according to a new report published this week. A report in the New England Journal of Medicine was published this week advising that the Moderna vaccine, much like its counterpart from Pfizer, will remain effective against COVID-19 for at least six months once both doses are administered.  The latest report comes after dozens of tests of those who received the shot during the study. With this research, using three separate tests that look for antibodies, the scientists found that pr…

SHARE

by Zak Failla
News
COVID-19: New Studies Shed More Light On Impact Of Blood Type On Virus COVID-19: New Studies Shed More Light On Impact Of Blood Type On Virus
Covid-19: New Studies Shed More Light On Impact Of Blood Type On Virus Two new studies are shedding light on the possible impact one's blood type has on contracting COVID-19. Findings by a team of European scientists published in the New England Journal of Medicine and based on research involving 1,980 severely ill patients found that those with Blood Type O had the lowest frequency of disease positivity and Blood Type A the highest. Separate studies, conducted at Columbia Presbyterian Hospital in New York and the Massachusetts General Hospital, do not share the European findings. Evidence was found in both those studies that those with Type O blood may be le…

SHARE

by Joe Lombardi
News
COVID-19: Those With This Blood Type Have Higher Chance Of Contracting Virus, Study Shows COVID-19: Those With This Blood Type Have Higher Chance Of Contracting Virus, Study Shows
Covid-19: Those With This Blood Type Have Higher Chance Of Contracting Virus, Study Shows Click here for an updated story - COVID-19: New Studies Shed More Light On Impact Of Blood Type On Virus Those who have one blood type are at higher risk of contracting COVID-19, and those in another are at a lower risk, a study has shown. The four blood types are A, B, AB and O. The findings by a team of European scientists were published in the New England Journal of Medicine. Blood Type O had the lowest frequency of disease positivity and Blood Type A the highest, the study revealed. A total of 1,980 patients described as having "severe" respiratory disease in seven Italian …

SHARE

by Joe Lombardi